National Korányi Institute of Tb and Pulmonology Trials: Revision history

3 December 2025

• curprev 03:5903:59, 3 December 2025‎ Larysse talk contribs‎ 13,948 bytes +7‎ No edit summary undo

2 December 2025

• curprev 13:3613:36, 2 December 2025‎ Lucas talk contribs‎ m 13,941 bytes +120‎ Update categories. undo

5 November 2024

• curprev 15:4815:48, 5 November 2024‎ Victor talk contribs‎ 13,821 bytes +12‎ No edit summary undo

16 May 2024

• curprev 19:4719:47, 16 May 2024‎ Francine talk contribs‎ 13,809 bytes +55‎ No edit summary undo

21 February 2024

• curprev 01:2101:21, 21 February 2024‎ Woloski talk contribs‎ 13,754 bytes −13‎ No edit summary undo
• curprev 01:2001:20, 21 February 2024‎ Woloski talk contribs‎ 13,767 bytes +13,767‎ Created page with "'''NCTID''': NCT00676507 '''Title''': Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy '''Study Summary''': Rationale: Vaccines made from gene-modified tumor cells may help the body build an immune response to kill tumor cells. It is not yet known whether vaccine therapy is more effective than a placebo as maintenance therapy in treatment of subjects with non-small cell lung cancer. Purpose: This r..."